JP2019509302A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509302A5
JP2019509302A5 JP2018549454A JP2018549454A JP2019509302A5 JP 2019509302 A5 JP2019509302 A5 JP 2019509302A5 JP 2018549454 A JP2018549454 A JP 2018549454A JP 2018549454 A JP2018549454 A JP 2018549454A JP 2019509302 A5 JP2019509302 A5 JP 2019509302A5
Authority
JP
Japan
Prior art keywords
vaccine
pcv2
immunogen
prrs virus
live attenuated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018549454A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019509302A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/056801 external-priority patent/WO2017162727A1/en
Publication of JP2019509302A publication Critical patent/JP2019509302A/ja
Publication of JP2019509302A5 publication Critical patent/JP2019509302A5/ja
Withdrawn legal-status Critical Current

Links

JP2018549454A 2016-03-23 2017-03-22 アルブミンを含むpcv2及びprrsウイルス感染症に対する混合ワクチン Withdrawn JP2019509302A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16161982.0 2016-03-23
EP16161982 2016-03-23
PCT/EP2017/056801 WO2017162727A1 (en) 2016-03-23 2017-03-22 A combination vaccine against pcv2 and prrs virus infection comprising albumin

Publications (2)

Publication Number Publication Date
JP2019509302A JP2019509302A (ja) 2019-04-04
JP2019509302A5 true JP2019509302A5 (enExample) 2020-03-12

Family

ID=55589749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018549454A Withdrawn JP2019509302A (ja) 2016-03-23 2017-03-22 アルブミンを含むpcv2及びprrsウイルス感染症に対する混合ワクチン

Country Status (7)

Country Link
US (1) US10953084B2 (enExample)
EP (1) EP3432921A1 (enExample)
JP (1) JP2019509302A (enExample)
CN (1) CN108778325A (enExample)
BR (1) BR112018069193A2 (enExample)
RU (1) RU2018137036A (enExample)
WO (1) WO2017162727A1 (enExample)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE462445T1 (de) 2005-01-13 2010-04-15 Boehringer Ingelheim Vetmed Prrs-impfstoffe
DK1926496T3 (da) 2005-09-09 2013-09-30 Intervet Int Bv PCV-2-vaccine
DK2371383T3 (en) 2005-12-29 2015-11-30 Boehringer Ingelheim Vetmed Use of a PCV2 immunogenic composition for reduction of clinical symptoms in pigs
AU2007333857B2 (en) 2006-12-15 2014-05-15 Boehringer Ingelheim Animal Health USA Inc. Treatment of pigs with PCV2 antigen
US8728487B2 (en) 2011-01-20 2014-05-20 Hua Wu Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
US9457073B2 (en) 2012-09-26 2016-10-04 University Of Manitoba Live attenuated replication-competent arteriviruses having decreased dub/deisgylating activity
CN105246505A (zh) * 2013-04-30 2016-01-13 勃林格殷格翰动物保健公司 PCV2a亚型(PCV2a)的ORF2蛋白用于交叉保护中的用途
TWI670085B (zh) * 2014-02-19 2019-09-01 荷蘭商英特威國際公司 液體穩定之豬病毒疫苗
CN104056265B (zh) * 2014-07-11 2016-04-27 江苏南农高科技股份有限公司 猪圆环病毒2型、猪繁殖与呼吸综合征二联疫苗及其制备方法

Similar Documents

Publication Publication Date Title
EP4218813A3 (en) High concentration anti-c5 antibody formulations
JP2019509300A5 (enExample)
JP5713672B2 (ja) 結核のワクチンおよびその使用方法
JP2011511754A5 (enExample)
PH12021550479A1 (en) Dengue vaccine unit dose and administration thereof
RU2018137034A (ru) Комбинированная вакцина против вируса pcv2 и инфекции mycoplasma hyopneumoniae
JP2010523711A5 (enExample)
JP2015520196A5 (enExample)
JP2012528794A5 (enExample)
JP2014508734A5 (enExample)
MX2020006662A (es) Vacuna combinada intradermica contra mycoplasma y circovirus porcino.
PH12013501373B1 (en) Bovine viral diarrhea virus type 1b vaccine compositions and methods
WO2017156511A8 (en) Live attenuated zika virus vaccine
RU2021112503A (ru) Поливалентная вакцина против м. hyo и её применение
DK3076997T3 (en) SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
US20170021009A1 (en) Heat Inactivated Poxvirus Improves Vaccination Results
BR112016012435A8 (pt) vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2
JP2023025210A5 (enExample)
JP2016534062A5 (enExample)
JP2019512518A5 (enExample)
JP2019509302A5 (enExample)
NO20090290L (no) Polyvalent vaksine mot salmonid alfavirusinfeksjoner
JP2017502058A5 (enExample)
RU2019136252A (ru) Вакцины, содержащие патогены свиней, для ассоциированного несмешанного применения
RU2018137033A (ru) Вакцина для внутрикожного применения против инфекции вируса pcv2 и prrs